Structure-Based design of 2-Arylamino-4-cyclohexylmethyl-5-nitroso-6-aminopyrimidine inhibitors of cyclin-Dependent kinases 1 and 2

Cancer Cell Cycles

1996 • 5,379 citations

To cycle or not to cycle: a critical decision in cancer

2001 • 1,429 citations

The United Kingdom Chemical Database Service

1996 • 1,076 citations

Pharmacological inhibitors of cyclin-dependent kinases

2002 • 528 citations

Preclinical and Clinical Development of Cyclin-Dependent Kinase Modulators

2000 • 501 citations

Cyclin-Dependent Kinase Inhibitors: Useful Targets in Cell Cycle Regulation

2000 • 325 citations

Structure-based design of a potent purine-based cyclin-dependent kinase inhibitor

2002 • 210 citations

Identification of Novel Purine and Pyrimidine Cyclin-Dependent Kinase Inhibitors with Distinct Molecular Interactions and Tumor Cell Growth Inhibition Profiles

2000 • 208 citations

Complexities in the development of cyclin-dependent kinase inhibitor drugs

2002 • 159 citations

Designing Inhibitors of Cyclin-Dependent Kinases

2002 • 91 citations

Probing the ATP Ribose-Binding Domain of Cyclin-Dependent Kinases 1 and 2 withO⁶-Substituted Guanine Derivatives

2002 • 85 citations

4-Alkoxy-2,6-diaminopyrimidine derivatives: inhibitors of cyclin dependent kinases 1 and 2

2003 • 48 citations